v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2026
Mar. 31, 2026
Current assets:    
Cash and cash equivalents $ 185,359 $ 209,024
Short-term investments 9,969 59,865
Research and development incentives receivable 0 1,619
Prepaid expenses and other current assets 5,479 8,611
Total current assets 200,807 279,119
Property, plant and equipment, net 11,858 12,974
Restricted cash 1,703 1,703
Other non-current assets 3,238 2,942
Right-of-use asset - operating leases 3,068 3,270
Right-of-use asset - finance leases 31,773 32,380
Total assets 252,447 332,388
Current liabilities:    
Accounts payable 4,261 6,671
Accrued expenses and other current liabilities 30,111 47,516
Operating lease liabilities, current 1,136 1,158
Finance lease liabilities, current 2,904 2,883
Total current liabilities 38,412 58,228
Operating lease liabilities, non-current 2,136 2,328
Finance lease liabilities, non-current 21,685 21,909
Long term debt, net of discount 84,114 83,308
Other liabilities, non-current 455 455
Total liabilities 146,802 166,228
Commitments and contingencies (Note 14)
Stockholders' equity    
Common stock, $0.001 par value; 150,000,000 shares authorized as of June 30, 2026 and March 31, 2026; 83,979,366 and 82,716,923 shares issued and outstanding as of June 30, 2026 and March 31, 2026, respectively 84 82
Additional paid-in capital 1,431,870 1,423,194
Accumulated deficit (1,332,285) (1,262,519)
Accumulated other comprehensive income 5,976 5,403
Total stockholders' equity 105,645 166,160
Total liabilities and stockholders' equity $ 252,447 $ 332,388